Caldwell Sutter Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.2K Sell
44
-6
-12% -$742 ﹤0.01% 639
2025
Q4
$6.29K Hold
50
﹤0.01% 608
2025
Q3
$7.32K Hold
50
﹤0.01% 592
2025
Q2
$7.8K Hold
50
﹤0.01% 571
2025
Q1
$8.23K Hold
50
﹤0.01% 566
2024
Q4
$8.15K Hold
50
﹤0.01% 575
2024
Q3
$9.77K Hold
50
﹤0.01% 558
2024
Q2
$8.67K Hold
50
﹤0.01% 566
2024
Q1
$8.46K Sell
50
-42
-46% -$7.87K ﹤0.01% 561
2023
Q4
$18.2K Hold
92
0.01% 476
2023
Q3
$16K Hold
92
0.01% 474
2023
Q2
$15.8K Buy
92
+36
+64% +$6.22K 0.01% 476
2023
Q1
$9.32K Buy
+56
New +$9.18K 0.01% 395

Other funds holding ZTS

Caldwell Sutter Capital's ZTS Position: Q1 2026 in Review

Caldwell Sutter Capital reduced its Zoetis (ZTS) stake by 12% in Q1 2026, selling an estimated $742 and leaving 44 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Caldwell Sutter Capital first reported a position in ZTS in Q1 2023 and has held it in 13 quarters since. The position peaked at $18.2K in Q4 2023. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Caldwell Sutter Capital held 44 shares of Zoetis worth $5.2K as of Q1 2026.
  • Caldwell Sutter Capital sold 6 Zoetis shares in Q1 2026, an estimated $742.
  • Zoetis made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #639 holding.
  • Caldwell Sutter Capital first reported a position in Zoetis in Q1 2023 and has held it in 13 quarters since.
  • Caldwell Sutter Capital's Zoetis position peaked at $18.2K in Q4 2023.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.